The MSB share price down 14%. The Mesoblast [ASX:MSB] posted a FY21 net loss of $98.8 million as the FDA asks for further trials of MSB’s emergency COVID treatment…
Biotech Stocks: Investing in Cutting-Edge Healthcare Innovations
Alcidion Posts Record FY21 Revenue but Shares Slide (ASX:ALC)
The Alcidion Group [ASX:ALC] reported record revenue for FY21 of $25.9 million.
The record revenue was not enough to increase the ALC shares price, with the Alcidion stock currently down 1.5%.
Trader’s Corner — Earnings Season Winners
Redbubble Ltd has had a wild ride over the past year, with a 1,300% rally from 50 cents to $7.22 in 10 months due to a leap in sales during the COVID shutdowns.
Incannex Healthcare Files for US IPO Sending the Shares 4% Higher (ASX:IHL)
Local pot stock Incannex Healthcare [ASX:IHL] is in traders’ sights today. The stock shares is currently up 4.36% and climbing.
Creso Pharma Secures New Win in Canada — Shares Up 8% (ASX:CPH)
Aussie pot stock Creso Pharma [ASX:CPH] share price is on the up today. The share price is currently trading 8% higher at time of writing.
AnteoTech Signs Distribution Agreement, ADO Shares Up 15% (ASX:ADO)
ADO share price is up as much as 18.9% in early trade, peaking at 22 cents. The AnteoTech (ASX:ADO) has signed a distribution agreement for its EuGeni reader and SARS-CoV-2 rapid diagnostic test in the Philippines.
